Why Breast Cancer Risk Takes Off After 50

Around one in seven women will develop a breast cancer, with 80% of cases occurring  after the age of 50. This age pattern is unusual. For many cancers, risk rises steadily with age as mutations accumulate in our cells. Breast cancer, however, follows a more striking pattern, with risk increasing sharply around midlife. This suggests that something beyond the gradual accumulation of mutations may be changing the breast’s vulnerability to cancer - and menopause is a leading candidate.

The hormonal shifts that accompany menopause profoundly reshape breast tissue, but exactly how these changes might influence cancer risk has remained unclear until recently.

The logic of researchers from the Universities of Cambridge and British Columbia was straightforward: study how breast tissue changes with age before and after menopause, and you can work out which mechanisms drive the disease. That, in turn, points to what might be done to slow the process down or head it off entirely.

They collected breast tissue from 500 women aged 15 to 86, taken during reduction surgery and biopsies. To understand the context in which those cells had been living, each sample was paired with data on the donor's hormonal and immune status.

The researchers then cut the tissue into very thin sections and used imaging techniques to examine 1,710 images containing a total of 3.3 million cells. This created a detailed map of how the breast changes across the lifespan - and several patterns stood out.

Breast Cells Divide Less After Menopause

Breast tissue is highly responsive to hormones, particularly oestrogen. As oestrogen levels fall around menopause, cell division and growth decrease across many breast cell types. 

The lobules, the structures responsible for producing milk, become progressively thinner and can almost disappear entirely. Epithelial cells, which line the milk-producing structures and are the cells from which most breast cancers arise, also become less abundant. At the same time, blood and lymphatic vessels are increasingly replaced by fatty tissue, potentially reducing immune surveillance and creating a more favourable environment for cancer to develop. 

Immune Defences Become Weaker and More Inflammatory 

The ageing breast also appears to undergo substantial changes in its immune landscape. Older tissue contained far lower densities of CD8 T cells (a type of immune cell that kills infected or cancerous cells), B cells (immune cells that produce antibodies), and dendritic cells (immune cells that present antigens to activate other immune cells) than young tissue. With fewer defenders on patrol, there is less chance that a mutated epithelial cell will be spotted and destroyed in time. 

The trend does not hold across the board, though. The researchers also observed proportion of M2 macrophages rises with age, and this particular type does the opposite: it suppresses the activity of the very cells that might have caught a nascent tumor. The microenvironment around the epithelium also grows more inflammatory, which again favors cancer. The researchers suspect these shifts may be a legacy of breastfeeding, when B cells work overtime producing immunoglobulins for the infant's immune system.

Cells Begin to Drift Apart

Perhaps the most intriguing finding was not simply which cells were present, but where they were in relation to one another.  

Breast cancer usually arises from epithelial cells, and after menopause it is precisely these cells that move away from their neighbours in the microenvironment, including immune cells. One possible explanation is the decline in oestrogen. Before menopause, oestrogen helps epithelial cells maintain interactions with surrounding immune cells but once menopause sets in, that contact is lost. New cancer cells can then evade detection not only because the defenses around them are weaker, but because they are simply out of reach.

The study provides a detailed picture of how breast tissue changes across the lifespan, but there are important limitations. The researchers  relied on just 40 key cellular proteins to identify cell types and states. In addition, information about factors such as the donors' hormonal histories, other conditions or ethnicity, so the findings may not hold true for every population.

Nevertheless, the picture that emerges is still a coherent one. Genetic errors accumulate in breast cells with the years, as they do everywhere else in the body. But in the breast a second process runs alongside them: after menopause the tissue itself turns hospitable. The lobules wind down, vessels turn to fat, immune defenses weaken, and the epithelial cells from which tumors most often grow drift out of contact with the very cells meant to police them. A mutation arising in that quiet, poorly policed tissue has far better odds than the same mutation would have had at thirty.

That is what makes a map this detailed worth having. Read together with the hormonal and immune data, it turns a vague association between menopause and risk into a list of specific changes, each of them a possible target. The nearer hope is treatment that works better than what is available now. The further one is preventive therapy: a way to stop the disease before it starts in the one woman in seven who would otherwise face it.

Original paper: http://nature.com/articles/s43587-026-01104-3

..............................................................................................................................................................

This article was written by Renata Tulakina and edited by Neave Smith, with graphics produced by Saba Keshan. If you enjoyed this article, be the first to be notified about new posts by signing up to become a WiNUK member (top right of this page)! Interested in writing for WiNUK yourself? Contact us through the blog page and the editors will be in touch.